Therapeutic effect of Sheng Mai San, a traditional Chinese medicine formula, on inflammatory bowel disease via inhibition of NF-κB and NLRP3 inflammasome signaling

• Váldodahkkit: Magnolia Muk-Lan Lee (Dahkki), Brandon Dow Chan (Dahkki), Yuen-Wa Ng (Dahkki), Tsz-Wing Leung (Dahkki), Tan-Yu Shum (Dahkki), Jian-Shu Lou (Dahkki), Wing-Yan Wong (Dahkki), William Chi-Shing Tai (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2024-08-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

IntroductionInflammatory bowel disease (IBD) is a globally emergent chronic inflammatory disease which commonly requires lifelong care. To date, there remains a pressing need for the discovery of novel anti-inflammatory therapeutic agents against this disease. Sheng Mai San (SMS) is a traditional Ch...